(Date:11/24/2009)...forpatientswithadvanced-stage,orrecurrentendometri...tCall/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(...edonendocrinetherapyandoncology,todayannouncedposi...otoxicpeptideconjugate,AEZS-108(formerlyAN-152),in...napersonalizedhealthcareapproach,thestudyselectedp...
(Date:11/24/2009)...ire-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )t...veChairman,willpresentatthe21stAnnualPiperJaffrayH...1,2009at10:00a.m.ET. ,, Toaccesstheliveandsubse...vestorRelationssectionofGenomicHealth,swebsiteat h...hewebsiteatleast15minutespriortothebeginningofthep...
(Date:11/24/2009)...ll/--CellTherapeutics,Inc.(CTI)(NasdaqandMTA:CTIC)...althCareConference.TheconferencewillbeheldDecember...sentonTuesday,December1at11:00a.m.EasternTimeinHol...nwillbeavailableat www.celltherapeutics.com ,andit...affrayHealthCareConference,NewYorkPalaceHotel,Holm...
(Date:11/23/2009)...carbon layer in which the carbon atoms are arrange...Carbon nanotubes are rolled-up sheets of graphene,... Graphene boasts some very special characteristics...rmal conductor, and reconciles such conflicting qu... graphene is impermeable to gases, which makes it ...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2Polymer with honeycomb structure 2... (July 17, 2008) Researchers at the U.S. Departmen...d their industrial partners have won two R&D 100 A... battery technologies. , Argonne scientists have ...ntroduction by R&D Magazine in 1964. Winning a pre...novation" by The Chicago Tribune -- provides proof...
... A new technique for growing single-crystal nanoro...could enable the development of smaller, more powe...ty from heat. , Researchers at Rensselaer Polytec...rowth of nanorods made up of two single crystals u...re also able to create "branched" structures by ca...
...July 17 Sonus,Pharmaceuticals, Inc. (Nasdaq: SNU... the NASDAQ Listing Qualifications Hearings Panel ...as determined to grant Sonus,request to continue t...Market. The Company,s continued listing on NASDAQ ...ns by August 29, 2008, including the,implementatio...
Other Biology Technology:Argonne researchers win 2 R&D 100 Awards 2Argonne researchers win 2 R&D 100 Awards 3Argonne researchers win 2 R&D 100 Awards 4'Nanosculpture' could enable new types of heat pumps and energy converters 2Sonus Pharmaceuticals Receives Favorable NASDAQ Decision 2Sonus Pharmaceuticals Receives Favorable NASDAQ Decision 3... pPIC3.5K vectors carry the kanamycin resistance g...n Pichia. Spontaneous generation of multiple inser...reased levels of Geneticin Reagent. Pichia transfo...and screened for their level of resistance to Gene...
Rabbit Anti-WW domain-containing oxidoreductase Antibody, Unconjugated from ABR-Affinity BioReagents
TBS Buffer from Invitrogen
Western Blot from Covance Research Products, Inc
Biology Products: